Patents by Inventor Chris Twelves

Chris Twelves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and uses of ET743 for treating cancer
    Patent number: 8119638
    Abstract: Et 743 is used in the preparation of a medicament for the treatment of the human body for cancer.
    Type: Grant
    Filed: June 28, 2007
    Date of Patent: February 21, 2012
    Assignee: Pharma Mar, S.A.
    Inventors: Esteban Cvitkovich, George Daniel Demetri, Cecilia Guzman, Jose Jimeno, Luis Lopez Lazaro, Jean Louis Misset, Chris Twelves, Daniel D. Von Hoff
  • APLIDINE TREATMENT OF CANCERS
    Publication number: 20090298752
    Abstract: Aplidine demonstrates considerable promise in phase (I) clinical trials for treatment of tumors, and various dosing regimes are given. Tumor reduction has been observed in several tumor types including renal carcinoma, colorectal cancer, lung carcinoid, medullary thyroid carcinomas and melanoma. It has also been found that aplidine has a role in inhibiting angiogenesis, complementing the anti-tumor activity.
    Type: Application
    Filed: December 23, 2008
    Publication date: December 3, 2009
    Applicant: PHARMA MAR, S.A.
    Inventors: Glynn Thomas Faircloth, Luis Paz-Ares, Chris Twelves
  • Compositions and Uses of Et 743 for Treating Cancer
    Publication number: 20070275942
    Abstract: Et 743 is used in the preparation of a medicament for the treatment of the human body for cancer.
    Type: Application
    Filed: June 28, 2007
    Publication date: November 29, 2007
    Applicant: Pharma Mar S.A.
    Inventors: Esteban Cvitkovich, George Demetri, Cecilia Guzman, Jose Jimeno, Luis Lazaro, Jean Misset, Chris Twelves, Daniel Von Hoff